Riskpilot← Back to searchSign inGet full accessPAUL HARTMANN A/S
A/SIn liquidationCVR 25091531Ørestads Boulevard 73Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19991 employeeswww.hartmann.info
Revenue 2024
DKK 158K
-97% vs 2023
EBITDA margin
100.0%
-61% vs 2023
Equity ratio
80.5%
Financial strength
Net profit 2024
DKK 230K
-43% vs 2023
| Revenue | DKK 158K | -97% |
| EBITDA | DKK 158K | -61% |
| Net profit | DKK 230K | -43% |
| Total assets | DKK 4,4M | -8% |
| Equity | DKK 3,5M | +7% |
| Employees | 1 | — |
Legal name
PAUL HARTMANN A/S
CVR number
25091531
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. december 1999
Share capital
DKK 1.002.001
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at drive virksomhed med produktion og/eller salg af operations-, sundhedspleje-, hygiene-og forbrugsprodukter og anden virksomhed, der efter bestyrelsens skøn er forbunden dermed, enten direkte eller indirekte gennem kapitalanbringelser i andre selskaber.
Address
Ørestads Boulevard 73
Phone
+4548220400
Email
invoice.scandinavia@hartmann.info
Website
www.hartmann.info
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6.780 | 7.506 | 5.566 | 5.974 | 158 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 913 | 1.511 | 397 | 403 | 158 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 913 | 1.511 | 397 | 403 | 158 |
| Net financials | -10 | -16 | 7 | 114 | 137 |
| Profit before tax | 903 | 1.496 | 404 | 517 | 295 |
| Tax | 95 | 330 | 90 | 114 | 65 |
| Net profit | 807 | 1.166 | 314 | 403 | 230 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3.315 | 3.636 | 3.940 | 4.747 | 4.377 |
| Equity | 1.411 | 2.577 | 2.891 | 3.294 | 3.524 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.905 | 1.059 | 1.049 | 1.453 | 853 |
| Total debt | 1.905 | 1.059 | 1.049 | 1.453 | 853 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
80.5%
This company
38.2%
Market median
+111% vs market
20202024
Return on equity
6.5%
This company
18.4%
Market median
-65% vs market
20202024
Net profit margin
146.1%
This company
8.1%
Market median
+1704% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PH Founder | Founder | 1999 |
MB Unofficial title | Unofficial title | 2025 |
| Former (4) | ||
MG Chief Executive Officer | Chief Executive Officer | 2023 – 2025 |
BT Management | Management | 1999 – 2013 |
CP Chief Executive Officer | Chief Executive Officer | 2014 – 2021 |
TI Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (14) | ||
| Board of Directors | 2005 – 2008 | |
| Board of Directors | 2013 – 2015 | |
| Chairman | 1999 – 2004 | |
| Chairman | 2004 – 2005 | |
| Board of Directors | 2015 – 2018 | |
| Chairman | 2015 – 2017 | |
| Chairman | 2005 – 2015 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2018 – 2025 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2015 – 2018 | |
| Chairman | 2017 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 1999 – 2002 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 1999 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PAUL HARTMANN A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paul Hartmann AG | Founder | 0 companies |
| Michael Geisel | Chief Executive Officer | 0 companies |
| Bengt Torsten Lars Gustafsson | Management | 0 companies |
| Morten Bruun-Larsen | Unofficial title | 0 companies |
| Caj Patrik Joakim Eurenius | Chief Executive Officer | 0 companies |
| Tanja Irmeli Storknér Nordhammar | Chief Executive Officer | 0 companies |
| Martin Dal Stenfeldt | Board of Directors | 0 companies |
| Christian Stenske | Board of Directors | 0 companies |
| Dr. Ulrich Hemel | Chairman | 0 companies |
| Friedrich Pohl | Chairman | 0 companies |
| Michael Brauner | Board of Directors | 0 companies |
| Jürgen Rauter | Chairman | 0 companies |
| Werner Casper | Chairman | 0 companies |
| Jens Dieter Marquard | Chairman | 0 companies |
| Axel Sasha Riemann | Board of Directors | 0 companies |
| Iryna Zhdanova | Board of Directors | 0 companies |
| Dietmar Wöhrmann | Board of Directors | 0 companies |
| Marc Perez | Chairman | 0 companies |
| Caj Patrik Joakim Eurenius | Board of Directors | 0 companies |
| Kahlich Johannes | Board of Directors | 0 companies |